116 related articles for article (PubMed ID: 30875030)
1. Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness.
Kamyab-Hesary K; Ghanadan A; Balighi K; Mousavinia SF; Nasimi M
Pathol Oncol Res; 2020 Apr; 26(2):885-891. PubMed ID: 30875030
[TBL] [Abstract][Full Text] [Related]
2. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
[TBL] [Abstract][Full Text] [Related]
3. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
4. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma.
Eng W; Tschen JA
Am J Dermatopathol; 2000 Feb; 22(1):26-9. PubMed ID: 10698212
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
6. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
7. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.
Ikenberg K; Pfaltz M; Rakozy C; Kempf W
J Cutan Pathol; 2012 Mar; 39(3):324-30. PubMed ID: 22335591
[TBL] [Abstract][Full Text] [Related]
9. Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.
Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
Plast Reconstr Surg; 2005 Feb; 115(2):367-75. PubMed ID: 15692338
[TBL] [Abstract][Full Text] [Related]
10. The Importance of Immunohistochemistry in the Evaluation of Tumor Depth of Primary Cutaneous Melanoma.
Pop AM; Monea M; Olah P; Moraru R; Cotoi OS
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980327
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma.
Parra-Medina R; Morales SD
Ann Diagn Pathol; 2017 Feb; 26():70-74. PubMed ID: 27594302
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens.
Scolyer RA; Li LX; McCarthy SW; Shaw HM; Stretch JR; Sharma R; Thompson JF
Melanoma Res; 2004 Aug; 14(4):263-8. PubMed ID: 15305156
[TBL] [Abstract][Full Text] [Related]
14. Detection of Occult Invasion in Melanoma In Situ.
Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
16. The new AJCC guidelines in practice: utility of the MITF immunohistochemical stain in the evaluation of single-cell metastasis in melanoma sentinel lymph nodes.
Hutchens KA; Heyna R; Mudaliar K; Wojcik E
Am J Surg Pathol; 2013 Jun; 37(6):933-7. PubMed ID: 23629445
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma.
Baisden BL; Askin FB; Lange JR; Westra WH
Am J Surg Pathol; 2000 Aug; 24(8):1140-6. PubMed ID: 10935655
[TBL] [Abstract][Full Text] [Related]
18. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.
Li LX; Scolyer RA; Ka VS; McKinnon JG; Shaw HM; McCarthy SW; Thompson JF
Am J Surg Pathol; 2003 Sep; 27(9):1197-202. PubMed ID: 12960803
[TBL] [Abstract][Full Text] [Related]
19. Clear cells in acral melanoma.
Schmuth M; Spötl L; Zelger B; Weinlich G; Zelger B
Eur J Dermatol; 2001; 11(1):21-4. PubMed ID: 11174132
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma.
Li W; Stall A; Shivers SC; Lin J; Haddad F; Messina J; Glass LF; Lyman G; Reintgen DS
Ann Surg; 2000 Jun; 231(6):795-803. PubMed ID: 10816622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
